Gordon Kathleen Md/Ophthalmologist is categorized under Ophthalmologists in Cary, NC and active since 2008.
Gordon Kathleen Md/Ophthalmologist was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Kathleen Gordon at the company’s single location by writing to 1110 Se Cary Parkway # 100, Cary, North Carolina NC 27518 or by phoning (919) 859-6771. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gordon Kathleen Md/Ophthalmologist |
Contact Person: | Kathleen Gordon |
Address: | 1110 Se Cary Parkway # 100, Cary, North Carolina 27518 |
Phone Number: | (919) 859-6771 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ophthalmologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Gordon Kathleen Md/Ophthalmologist was started in 2008 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kathleen Gordon for inquiries that concern Gordon Kathleen Md/Ophthalmologist by calling the company number (919) 859-6771, as your correspondence is most welcome. Additionally, the physical location of the single location of Gordon Kathleen Md/Ophthalmologist can be found at the coordinates 35.743223,-78.762688 as well as the street address 1110 Se Cary Parkway # 100 in Cary, North Carolina 27518.
For its online presence, you may visit Gordon Kathleen Md/Ophthalmologist’s website at and engage with its social media outlets through on Twitter and on Facebook.